FedEx Express, a subsidiary of FedEx Corp., has unveiled its ‘FedEx Life Science Centre’ in Mumbai, setting a benchmark in the clinical trial supply chain in India and globally.

The new capability will meet and support the clinical trial storage and logistics requirements of healthcare customers both within the India market and those shipping to India from around the world. The facility has ensured compliance with quality and regulatory requirements of the healthcare industry.

Key features of the new FedEx Life Science Centre include covering all three temperature-controlled zones- Controlled Ambient (15°C to 25°C); Refrigerated (2°C to 8°C); and Frozen -20°C and Deep Frozen -80°C.

The new centre also offers 24/7 monitoring and alarms for immediate response and intervention; destruction services for returned Investigational Medicinal Products (IMPs); Equipped with document storage and a secure archival facility with fire-safe walls.

Nitin Navneet Tatiwala, Vice President of FedEx Express, Marketing, Middle East, India Sub-continent & Africa (MEISA) said, “With FedEx having deep expertise in handling critical clinical trial shipments, the launch of FedEx Life Science Centre (LSC) will act as a one stop shop for all clinical trial storage and distribution requirements of healthcare customers in India. The new centre is in addition to FedEx’s current LSCs in Japan, South Korea, Singapore, the USA, and the Netherlands – making it a global network of storage and distribution depots to support our healthcare and pharmaceutical customers.”

FedEx, at present, offers door-to-door delivery across more than 6,000 postal codes within India for time-critical and temperature-controlled healthcare shipments. This service ensures express delivery within 24 to 48 hours in major metropolitan areas such as Mumbai, Bengaluru, Hyderabad, Pune, Chennai, Delhi, Kolkata, and Ahmedabad. FedEx has invested in a robust global healthcare supply chain with over 90 cold-storage facilities worldwide to acknowledge the diverse compliance and distribution needs.